Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphoma 2006: classification and treatment.

James O Armitage1, Philip J Bierman, R Gregory Bociek

  • 1Section of Oncology/Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198, USA. joarmita@unmc.edu

Oncology (Williston Park, N.Y.)
|April 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.

Cancer journal (Sudbury, Mass.)·2026
Same author

Persistence of PET scan positivity after chemoimmunotherapy for DLBCL.

Blood advances·2026
Same author

A Phase II Trial of Geriatric Assessment-Guided Selection of Treatment Intensity in Older Adults With AML.

American journal of hematology·2025
Same author

Primum succurrere; first hasten to help.

The oncologist·2025
Same author

Academic and community cancer center collaboration in acute myeloid leukemia: a road map to optimize care delivery.

Leukemia & lymphoma·2025
Same author

Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma: A Narrative Review.

JAMA oncology·2025
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

Significant progress in non-Hodgkin

Area of Science:

  • Hematology
  • Oncology

Background:

  • Non-Hodgkin's lymphoma management has evolved significantly over the past 20 years.
  • Improved classification, diagnosis, staging, and treatments have enhanced patient outcomes.
  • Cure is now a realistic goal for many patients with these lymphoid malignancies.

Purpose of the Study:

  • To provide an overview of advancements in non-Hodgkin's lymphoma management over the last two decades.
  • To highlight key developments in diagnostic techniques and therapeutic strategies.
  • To discuss progress across various specific types of non-Hodgkin's lymphoma.

Main Methods:

  • Review of recent literature and clinical practice guidelines.
  • Description of novel diagnostic tools, including gene array studies and immunophenotyping.

Related Experiment Videos

  • Summary of emerging and established treatment modalities.

    • Main Results:

    • Enhanced precision in lymphoma classification and staging.
    • Introduction of effective new treatment regimens leading to improved survival rates.
    • Gene array studies and immunophenotyping offer more accurate diagnoses.

    Conclusions:

    • Advances in non-Hodgkin's lymphoma management have substantially improved patient prognoses.
    • The integration of advanced diagnostics and novel therapies offers greater potential for cure.
    • Continued research and development are crucial for further progress in treating these cancers.